Author: Kevadiya, Bhavesh D.; Machhi, Jatin; Herskovitz, Jonathan; Oleynikov, Maxim D.; Blomberg, Wilson R.; Bajwa, Neha; Soni, Dhruvkumar; Das, Srijanee; Hasan, Mahmudul; Patel, Milankumar; Senan, Ahmed M.; Gorantla, Santhi; McMillan, JoEllyn; Edagwa, Benson; Eisenberg, Robert; Gurumurthy, Channabasavaiah B.; Reid, St Patrick M.; Punyadeera, Chamindie; Chang, Linda; Gendelman, Howard E.
Title: Pharmacotherapeutics of SARS-CoV-2 Infections Cord-id: luf8yelu Document date: 2021_1_6
ID: luf8yelu
Snippet: The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Compl
Document: The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Complete viral eradication will be achieved through an effective, safe and preventative vaccine. To now provide a comprehensive summary for each of the pharmacotherapeutics and preventative strategies being offered or soon to be developed for SARS-CoV-2. [Image: see text]
Search related documents:
Co phrase search for related documents- abdominal pain and active sars infection: 1
- abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
- abdominal pain and acute cardiac: 1, 2, 3, 4, 5, 6, 7
- abdominal pain and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71
- abdominal pain and acute kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- abdominal pain and acute multisystem inflammatory syndrome: 1, 2, 3, 4, 5, 6, 7
- abdominal pain and additional investigation: 1
- abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
- abdominal pain and low mortality: 1, 2
- abdominal pain and low mortality rate: 1, 2
- abdominal pain and lung cancer: 1
- abdominal pain and lung disease: 1, 2, 3, 4, 5, 6, 7
- abdominal pain and lung tissue: 1, 2
- abdominal pain and lupus erythematosus: 1, 2, 3, 4
- abdominal pain and macrophage activation: 1, 2, 3, 4
- abdominal pain and macrophage activation syndrome: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date